Rchr
J-GLOBAL ID:200901005104508766
Update date: Oct. 02, 2022
Fujikura Hisanori
フジクラ ヒサノリ | Fujikura Hisanori
Affiliation and department:
Former Institution / Organization TOKAI UNIVERSITY SCHOOL OF MEDICINE
About Former Institution / Organization TOKAI UNIVERSITY SCHOOL OF MEDICINE
Search "Former Institution / Organization TOKAI UNIVERSITY SCHOOL OF MEDICINE"
Research field (2):
Plastic and reconstructive surgery
, Cardiology
Research keywords (3):
再生医学
, 遺伝子
, 虚血性心疾患
Research theme for competitive and other funds (4):
2003 - 2006 虚血性心疾患に対する低侵襲性遺伝子治療法の開発
2003 - 2006 -
2000 - 2005 虚血性心疾患の治療
2000 - 2005 -
MISC (17):
Phagocytes transfected with biodegradable gelatin allow tissure-tageted and lessinvasivegene therapy. 日本循環器学会総会・学術集会. 2003
完全房室ブロックが遷延し恒久ペースメーカが植え込み術を要したたこつぼ型心筋症の2例. 第186回日本循環器学会関東甲信越地方会 日本循環器学会. 2003
AMINO Mari, YOSHIOKA Koichiro, IWATA Osamu, FUJIKURA Hisanori, DEGUCHI Yoshiaki, BAN Kazunobu, SHIINA Yutaka, GOTO Shinya, HANDA Shunnosuke, TANABE Teruhisa, et al. Efficacy of Nifekalant Hydrochloride for Life-Threatening Ventricular Tachyarrhythmias in Patients With Resistance to Lidocaine : A Study of Patients With Out-of-Hospital Cardiac Arrest. J Cardiol. 2003. 41. 3. 127-134
AMINO Mari, YOSHIOKA Koichiro, IWATA Osamu, FUJIKURA Hisanori, DEGUCHI Yoshiaki, BAN Kazunobu, SHIINA Yutaka, GOTO Shinya, HANDA Shunnosuke, TANABE Teruhisa, et al. Efficacy of Nifekalant Hydrochloride for Life-Threatening Ventricular Tachyarrhythmias in Patients With Resistance to Lidocaine : A Study of Patients With Out-of-Hospital Cardiac Arrest. J Cardiol. 2003. 41. 3. 127-134
Phagocytes transfected with biodegradable gelatin allow tissure-tageted and lessinvasivegene therapy. 2003
more...
Education (4):
- 2003 Tokai University
- 2003 Tokai University Graduate School of Medicine
- 1997 Tokai University School of Medicine Faculty of Medicine
- 1997 Tokai University School of Medicine
Professional career (1):
医学博士 (東海大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM